Cargando…
Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19
BACKGROUND: Severe coronavirus disease 2019 (COVID-19) is associated with systemic hyper-inflammation. An adaptive interaction between gut microbiota and host immune systems is important for intestinal homeostasis and systemic immune regulation. The association of gut microbial composition and funct...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170741/ https://www.ncbi.nlm.nih.gov/pubmed/37161621 http://dx.doi.org/10.1186/s13099-023-00546-z |
_version_ | 1785039285805645824 |
---|---|
author | Talukdar, Daizee Bandopadhyay, Purbita Ray, Yogiraj Paul, Shekhar Ranjan Sarif, Jafar D’Rozario, Ranit Lahiri, Abhishake Das, Santanu Bhowmick, Debaleena Chatterjee, Shilpak Das, Bhabatosh Ganguly, Dipyaman |
author_facet | Talukdar, Daizee Bandopadhyay, Purbita Ray, Yogiraj Paul, Shekhar Ranjan Sarif, Jafar D’Rozario, Ranit Lahiri, Abhishake Das, Santanu Bhowmick, Debaleena Chatterjee, Shilpak Das, Bhabatosh Ganguly, Dipyaman |
author_sort | Talukdar, Daizee |
collection | PubMed |
description | BACKGROUND: Severe coronavirus disease 2019 (COVID-19) is associated with systemic hyper-inflammation. An adaptive interaction between gut microbiota and host immune systems is important for intestinal homeostasis and systemic immune regulation. The association of gut microbial composition and functions with COVID-19 disease severity is sparse, especially in India. We analysed faecal microbial diversity and abundances in a cohort of Indian COVID-19 patients to identify key signatures in the gut microbial ecology in patients with severe COVID-19 disease as well as in response to different therapies. The composition of the gut microbiome was characterized using 16Sr RNA gene sequences of genomic DNA extracted from faecal samples of 52 COVID-19 patients. Metabolic pathways across the groups were predicted using PICRUSt2. All statistical analyses were done using Vegan in the R environment. Plasma cytokine abundance at recruitment was measured in a multiplex assay. RESULTS: The gut microbiome composition of mild and severe patients was found to be significantly different. Immunomodulatory commensals, viz. Lachnospiraceae family members and Bifidobacteria producing butyrate and short-chain fatty acids (SCFAs), were under represented in patients with severe COVID-19, with an increased abundance of opportunistic pathogens like Eggerthella. The higher abundance of Lachnoclostridium in severe disease was reduced in response to convalescent plasma therapy. Specific microbial genera showed distinctive trends in enriched metabolic pathways, strong correlations with blood plasma cytokine levels, and associative link to disease outcomes. CONCLUSION: Our study indicates that, along with SARS-CoV-2, a dysbiotic gut microbial community may also play an important role in COVID-19 severity through modulation of host immune responses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13099-023-00546-z. |
format | Online Article Text |
id | pubmed-10170741 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101707412023-05-11 Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 Talukdar, Daizee Bandopadhyay, Purbita Ray, Yogiraj Paul, Shekhar Ranjan Sarif, Jafar D’Rozario, Ranit Lahiri, Abhishake Das, Santanu Bhowmick, Debaleena Chatterjee, Shilpak Das, Bhabatosh Ganguly, Dipyaman Gut Pathog Research BACKGROUND: Severe coronavirus disease 2019 (COVID-19) is associated with systemic hyper-inflammation. An adaptive interaction between gut microbiota and host immune systems is important for intestinal homeostasis and systemic immune regulation. The association of gut microbial composition and functions with COVID-19 disease severity is sparse, especially in India. We analysed faecal microbial diversity and abundances in a cohort of Indian COVID-19 patients to identify key signatures in the gut microbial ecology in patients with severe COVID-19 disease as well as in response to different therapies. The composition of the gut microbiome was characterized using 16Sr RNA gene sequences of genomic DNA extracted from faecal samples of 52 COVID-19 patients. Metabolic pathways across the groups were predicted using PICRUSt2. All statistical analyses were done using Vegan in the R environment. Plasma cytokine abundance at recruitment was measured in a multiplex assay. RESULTS: The gut microbiome composition of mild and severe patients was found to be significantly different. Immunomodulatory commensals, viz. Lachnospiraceae family members and Bifidobacteria producing butyrate and short-chain fatty acids (SCFAs), were under represented in patients with severe COVID-19, with an increased abundance of opportunistic pathogens like Eggerthella. The higher abundance of Lachnoclostridium in severe disease was reduced in response to convalescent plasma therapy. Specific microbial genera showed distinctive trends in enriched metabolic pathways, strong correlations with blood plasma cytokine levels, and associative link to disease outcomes. CONCLUSION: Our study indicates that, along with SARS-CoV-2, a dysbiotic gut microbial community may also play an important role in COVID-19 severity through modulation of host immune responses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13099-023-00546-z. BioMed Central 2023-05-10 /pmc/articles/PMC10170741/ /pubmed/37161621 http://dx.doi.org/10.1186/s13099-023-00546-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Talukdar, Daizee Bandopadhyay, Purbita Ray, Yogiraj Paul, Shekhar Ranjan Sarif, Jafar D’Rozario, Ranit Lahiri, Abhishake Das, Santanu Bhowmick, Debaleena Chatterjee, Shilpak Das, Bhabatosh Ganguly, Dipyaman Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 |
title | Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 |
title_full | Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 |
title_fullStr | Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 |
title_full_unstemmed | Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 |
title_short | Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 |
title_sort | association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in indian patients with covid-19 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170741/ https://www.ncbi.nlm.nih.gov/pubmed/37161621 http://dx.doi.org/10.1186/s13099-023-00546-z |
work_keys_str_mv | AT talukdardaizee associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19 AT bandopadhyaypurbita associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19 AT rayyogiraj associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19 AT paulshekharranjan associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19 AT sarifjafar associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19 AT drozarioranit associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19 AT lahiriabhishake associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19 AT dassantanu associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19 AT bhowmickdebaleena associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19 AT chatterjeeshilpak associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19 AT dasbhabatosh associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19 AT gangulydipyaman associationofgutmicrobialdysbiosiswithdiseaseseverityresponsetotherapyanddiseaseoutcomesinindianpatientswithcovid19 |